Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others

Global discussions are ongoing on how to stimulate antibiotic research and development in order to provide patients with new antibiotics able to address the challenges of antimicrobial resistance. In this supplement, we present nine articles derived from the research performed as part of the Innovat...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of law, medicine & ethics medicine & ethics, 2018-06, Vol.46 (1_suppl), p.5-8
Main Authors: Bettiol, Esther, Hackett, Judith, Harbarth, Stephan
Format: Article
Language:English
Subjects:
Antibiotics
Antimicrobial agents
Economic models
Health technology assessment
Incentives
Initiatives
Innovations
Market entry
Public health
R&D
Research & development
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Global discussions are ongoing on how to stimulate antibiotic research and development in order to provide patients with new antibiotics able to address the challenges of antimicrobial resistance. In this supplement, we present nine articles derived from the research performed as part of the Innovative Medicine Initiative-funded DRIVE-AB project and others. These publications provide new evidence and arguments in the debate around economic incentives to stimulate antibiotic innovation, including characteristics, implementation and governance.
ISSN:1073-1105
1748-720X
DOI:10.1177/1073110518782910